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ABSTRACT
Objective: An important clinical gap reported by primary care physicians (PCPs) in managing knee
osteoarthritis patients is the lack of validated tools to help them guide conservative treatment decision-
making. This study aimed at evaluating the clinical utility of adding to current medical management
(CMM) by PCPs, a dynamic knee kinesiography (KneeKG) exam assessing biomechanical risk factors
linked to osteoarthritis progression.
Design: In this 6-month cluster randomized controlled trial, primary care clinics were randomized into
three groups: 1-CMM by PCPs, 2-CMM+KneeKG, and 3-CMM+KneeKG+Education (a self-management
education session and two follow-up group meetings). Primary outcomes were scores on the Knee
Injury and Osteoarthritis Outcome Score (KOOS) subscales and overall score.
Results: Of the 894 patients referred from 87 clinics, 515 participated, 449 (87.2%) completed the study.
At 6-month follow-up, patients in both KneeKG groups reported statistically significant improvement on
the KOOS overall score (Group2: +5.5; Group3: +5.0), and on the symptoms, pain, and activities of daily
living subscales compared to control group (all p < 0.05). They also reported significantly higher
satisfaction levels with global care (both p < 0.01). Group 3-CMM+KneeKG+Education showed statisti-
cally significant improvements in objective functional tests as well as greater global impression of
change in pain, function, quality of life, and global condition (all p < 0.05).
Conclusions: Results demonstrated significant improvements in terms of pain, function, and satisfac-
tion in KneeKG groups relative to the CMM. Adding education and supervision further improves clinical
outcomes. These findings may support the added value of a KneeKG exam in assisting PCPs in the
management of knee osteoarthritis patients.
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Introduction
Knee osteoarthritis (OA) is a multifactorial disease affected by
mechanical factors [1]. It is a common reason for adults above
45 years to consult their primary care physician (PCP) [2]. In
their current medical management (CMM), PCPs can select
from a number of modalities which are recommended by
various guidelines (drugs for pain management, magnetic
resonance imaging, injections, weight management, exercises,
referral to physiotherapy …), according to the individual
needs of their patients, and thus OA management is highly
variable [3–5]. An important clinical gap for managing knee
OA patients identified by PCPs is the lack of validated assess-
ment tools to support clinical decision-making to guide con-
servative care pathways [6,7].
Knee OA is a chronic progressive disease whose course
varies from patient to patient based on its underlying etiology
and risk factors [1]. These risk factors may be modifiable or
non-modifiable. Dynamic mechanical markers have been iden-
tified as risk factors for disease progression and appear to be
more associated with pain and functional limitations than
static mechanical factors (e.g., varus thrust vs radiographic
femoro-tibial angle) [1]. Biomechanical interventions, which
can address and correct specifically identified misalignment
issues, are well recognized as an appropriate treatment mod-
ality for knee OA patients [3,8]. Although gait abnormality
assessment by the PCP is part of the physical examination of
knee OA patient [9], they often skip this aspect for various
reasons (lack of time, restricted space, high variability, and
difficulty to identify small dynamic misalignments) [9,10].
CONTACT Nicola Hagemeister nicola.hagemeister@etsmtl.ca Laboratoire de recherche en imagerie et orthopédie de l’École de technologie supérieure,
Research centre of the Centre hospitalier de l’Université de Montréal, 900 Saint-Denis St, 11th floor, Montreal, Quebec H2X 0A9, Canada
TRIAL REGISTRATION: ‘Osteoarthritis project’ is registered with study ID ISRCTN16152290 and available at http://www.isrctn.com/ISRCTN16152290.
Supplemental data for this article can be accessed here.
POSTGRADUATE MEDICINE
https://doi.org/10.1080/00325481.2019.1665457
© 2019 Informa UK Limited, trading as Taylor & Francis Group
Knee kinesiography represents a promising modality for objec-
tive knee assessment by measuring specific misalignments
during gait, to assist PCPs in their decision-making process.
Knee kinesiography assessments can be performed by a health
care professional (HCP) using validated tools such as the
KneeKG™ system (Emovi Inc., Canada), designed to objectively
measure mechanical markers in a three-dimensional (3D)
dynamic, weight-bearing context [11,12].
We designed a cluster randomized clinical trial to evaluate
the clinical utility of a knee kinesiography assessment as part
of the patients’ care pathway to improve their condition based
on specific outcomes. The aim is to assess a global care
strategy aiming to provide patients with a personalized treat-
ment addressing specific misalignments identified by the
KneeKG.
We hypothesized that the addition of a knee kinesiography
exam to CMM would help PCPs in their patient management
to guide treatment and thereby improve patient clinical out-
comes at 6 months. These outcomes would be further
improved with an additional educational program.
Materials and methods
Study design
This was a multi-arm, cluster design randomized controlled
trial (RCT), meaning that clusters of individuals rather than
independent individuals are allocated to intervention groups
[13]. Patients were assessed from recruitment through the
intervention period and at 6-month follow-up. The study is
compliant with the Consolidated Standards of Reporting Trials
(CONSORT) statement for reporting RCTs [14]. It was approved
by the Research Ethics Boards of the École de technologie
supérieure (CE.14.339) and the Centre hospitalier de
l’Université de Montréal (MP-02-2015-5891). All patients gave
written, informed consent prior to study procedures. The
study is registered (ID ISRCTN16152290) and available at
http://www.isrctn.com/ISRCTN16152290.
Patient recruitment
PCPs from primary care clinics throughout the Province of
Quebec enrolled consecutive eligible patients with a clinical
diagnosis of OA (pain, crepitus, swelling and stiffness) [15]
who consented to participate in the study. Eligibility was
assessed by the research team. Inclusion criteria included 1)
OA as the main cause of the knee pain, 2) Patient-rated worst
pain in the 7 days prior to assessment ≥ 4 on a 0–10 pain
intensity scale, 3) Ability to read and understand French,
and 4) A Kellgren-Lawrence (KL) grade ≥ 2 on radiographs
[16]. KL grade was determined by a fellowship-trained muscu-
loskeletal radiologist through a standardized radiographic
examination which included an anteroposterior view of both
knees in standing position, a non-weight bearing lateral view,
and an axial view of the affected knee. If a patient met inclu-
sion criteria for both knees, only data from the most painful
knee were collected. Exclusion criteria included 1) being on
a waiting list for total knee replacement and 2) having met an
OA specialist in the past, to ensure that all patients were
indeed treated in primary care. 3) Patients suffering from
rheumatoid arthritis, active cancer, and being pregnant were
also excluded.
Randomization and interventions
All eligible patients from a single clinic received the same
intervention and were defined as a cluster. A blinded statisti-
cian who was not involved with study procedures or data
collection generated the randomization sequence using
a computer-generated random listing of the groups and
applying a pre-specified seed. Participating clinics were ran-
domized 1:1:1 with a permuted block (size of 3 and 6) design
to one of the 3 groups: 1) a control group with patients
receiving CMM (Group 1-CMM), 2) a group receiving CMM
plus KneeKG (Group 2-CMM+KneeKG), and 3) a group receiv-
ing CMM plus KneeKG plus an educational program (Group
3-CMM+KneeKG+Education). This program consists of a one-
hour self-management education session and two follow-up
supervised group meetings. In the two KneeKG groups (2
and 3), all KneeKG exams at baseline were combined with
a standardized musculoskeletal assessment and both were
performed by a trained therapist (physical therapist, kinesiol-
ogist, or physical rehabilitation therapist). Figure 1 summarizes
the care pathway for each of the intervention groups.
Knee kinesiography examination
The KneeKG exam takes about 20 minutes and uses the KneeKG™
validated marker attachment brace [12] which is placed on the
patient’s lower limb (Figure 2). This brace allows the reduction of
tissue artifacts that render gait analysis acquisitions with skin
markers inaccurate for small joint rotations. 3D knee kinematics
are captured during walking on a conventional treadmill at a self-
determined comfortable speed. Accuracy of the measurement
device in coronal and axial rotations has been established at 0.4°
and 2.3° respectively and its reliability (intra- and inter-raters)
achieved intra-class coefficients of 0.88 to 0.94 for measuring 3D
knee kinematics [17,18]. The KneeKG™ software automatically
identifies presence of mechanical markers known to be risk factors
of knee OA progression, such as varus thrust or offset toward
internal tibial rotation (all detailed in Table SM1, Supplemental
material). Further details are available on validation [19–21].
Report from knee kinesiography examination and
recommendations
Each PCP whose patients were randomized to Group 2-CMM
+KneeKGor 3-CMM+KneeKG+Education received aKneeKG report
from the therapist, summarizing findings of his/her musculoskele-
tal assessment and the objective mechanical markers identified.
This report also listed suggested personalized treatment recom-
mendations (such as mechanical interventions, specific sports
activities …) and a personalized home-based exercise program
targeting the identified mechanical knee deficiencies (all detailed
in Figure SM1, Supplemental material). PCPs in Group 2-CMM
+KneeKG were asked to follow up with their patients to explain
KneeKG exam results and to provide their treatment recommen-
dations as well as those of the therapist, based on these findings.
2 A. CAGNIN ET AL.
The care pathway for patients from Group 3-CMM+KneeKG
+Education additionally included an educational program: they
met with the therapist within 2 weeks after the KneeKG exam for
an education session where he/she demonstrated how
recommended exercises should be performed and how patients
canmanage their pain. Two subsequent group sessions supervised
by the therapist were provided at 6 weeks and 4months to adjust
the nature and intensity of the exercises.
Therapist training
The therapists involved in this study (N = 14) received stan-
dardized training from an experienced therapist. The proce-
dures for which they were trained included 1) performing the
KneeKG exam, 2) analyzing the KneeKG results, 3) conducting
the musculoskeletal assessment, 4) generating targeted
recommendations based on 2) and 3). The therapist was the
technical person who performed the KneeKG exam, analogous
to a radiology technician who performs X-rays. The therapist
also recommended an appropriate exercise program, and
served as a support for the PCP in delivering the educational
program for Group 3-CMM+KneeKG+Education (5) explaining
the results of the exam and the exercises, and 6) conducting
the group meetings).
PCP training
Given that PCP is the primary decision-maker across all inter-
vention groups, for clinics randomized to the two KneeKG
groups, the PCP received a continuing medical education
training session (45- to 60-minute), approved by the provincial
federation of PCPs, to gain a better understanding of the role
of mechanical factors in OA disease progression, correlations
with patients’ symptoms, and how to address them through
mechanical interventions or exercises.
Outcome measures
Randomized patients completed a series of online question-
naires via the Research Electronic Data Capture platform [22]
Figure 1. The care pathway for each of the intervention groups.
Figure 2. The attachment brace of the KneeKG™ system.
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or by phone if they were unable to do so by themselves or did
not have access to the internet.
Primary outcome
The primary outcome was the Knee Injury and Osteoarthritis
Outcome Score [23] (KOOS) (subscales scores and the overall
score), assessed at baseline and 6-month follow-up. The KOOS
is a valid and reliable instrument which assesses the impact of
knee OA on five domains: symptoms, pain, activities of daily
living (ADL), sports and recreation (Sports/Rec), and quality of
life (QOL). An overall KOOS score can also be calculated [24].
Scores on the subscales and overall scale range from 0
(extreme symptoms) to 100 (no symptoms). For each score,
a minimal improvement of 12% from baseline is considered to
be clinically important (Minimal Clinical Important Difference
(MCID)) [25].
Secondary outcomes
Objective functional status was assessed at baseline and
6-month follow-up with the isokinetic quadriceps strength
test and the 30-seconds Chair Stand test (30sCST) by the
therapists who performed the musculoskeletal assessment.
The quadriceps strength test has been shown to be a reliable
measure which correlates well with pain intensity and dis-
ability [26,27]. The 30sCST, which assesses the number of
maximum sit-to-stand repetitions performed in 30 seconds,
is recommended by the Osteoarthritis Research Society
International (OARSI) as a component of the minimal core
set of performance-based physical function tests for knee OA
and has demonstrated acceptable levels on both intra-/inter-
rater reliability, and measurement error [28,29]. MCID for
both tests are respectively +15% Nm/Kg and +2.0 repetitions
from baseline [30,31]. Due to financial considerations, these
tests were performed only in a subgroup of patients within
each intervention arm (i.e., N = 226: 75 in Group 1-CMM, 73 in
Group 2-CMM+KneeKG, and 78 in Group 3-CMM+KneeKG
+Education).
At 6-month follow-up only, the Patient Global Impression
of Change Scale (PGICS) and Patient Satisfaction
Questionnaire were administered [32]. The PGICS is
a measure which is recommended by the Initiative on
Methods, Measurement, and Pain Assessment in Clinical
Trials (IMMPACT) group [33]. It targets four different domains:
pain, function, quality of life, and global condition. Each
domain was measured with a 7-point Likert scale (from
‘Considerably improved’ to ‘Considerably deteriorated’) and
patients were also asked to estimate their pain relief (11-
point scale from 0% no relief to 100% complete relief). The
Patient satisfaction, also recommended by the IMMPACT
group [33], was assessed with a 7-point Likert scale (from
‘Very dissatisfied with the global care I received’ to ‘Very
satisfied’). The following additional item was assessed: ‘I do
not have the impression that my knee OA had been taken
care of’. PCPs from each group were also invited to indicate
their satisfaction level with the same 7-point Likert scale in
terms of tools and means they had at their disposal during
the study to guide and manage their knee OA patients.
At 6-month follow-up, patients from the two KneeKG
groups were asked if they had followed the recommended
exercises for at least 3 months to assess the impact of the
educational program on adherence to home-based recom-
mended exercises. Attendance at physical therapy sessions
was also monitored at 3 and 6-month follow-ups in the
three groups.
Sample size
Sample size was estimated based on the available literature
and preliminary unpublished data as few cluster randomized
trials have been carried out in the knee OA primary care
population. We predicted a 10-point difference between the
three groups at 6-month follow-up on the overall KOOS score
and considered a standard deviation to the mean of 17 (pre-
liminary data). We estimated that the inclusion of 61 patients
per group would provide an 80% statistical power with an
alpha of 0.05 and allow a 15% patient loss at the 6-month
follow-up. Based on Campbell’s and Cosby’s, recommenda-
tions, we selected an intra-cluster correlation coefficient of
0.03 and increased the sample size per group by 30% to
take into account the loss of power due to clustering [34,35].
The sample size estimation was performed with R software
[36] and was fixed at a minimum of 100 patients per group.
Statistical analysis
All analyses were conducted by an independent biostatistician
blinded to the group assignment. Modified intention-to-treat
analyses were carried out using data collected in patients who
completed both baseline and follow-up measures at 6 months
regardless of whether or not they were compliant with the
recommendations. Linear mixed models adjusting for the clus-
ter study design were used to assess between-group differ-
ences at baseline [37]. Time (baseline/6-month) was then
added to the same models as a variable to assess the time*-
group interaction on outcome scores between the three
groups.
When the interaction was statistically significant (p ≤ 0.05),
post-hoc analyses were performed to confirm that there were
significant differences among the groups on delta scores
(6-month scores minus baseline scores) using the same mod-
els. Chi-square tests were used to assess between-group dif-
ferences on the PGICS and patient treatment satisfaction scale.
Finally, sensitivity analysis was carried out to assess the
impact of loss to follow-up on the primary outcome (KOOS):
baseline scores were imputed at 6-month follow-up for
patients who withdrew after randomization (but who com-
pleted baseline questionnaires) and the above statistical ana-
lyses were re-run. All analyses were performed using Statistical
Analysis System Software version 9.4 (SAS Institute, Cary,
North Carolina).
Results
Baseline characteristics
Participants were enrolled between August 2015 and October
2017. The last patient completed the study April 3rd, 2018.
PCPs from 87 clinics referred 894 patients: 515 (57.6%) were
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randomized to one of the intervention groups (Figure 3).
Given that the randomization unit was the clinic, from each
of which were recruited a different number of patients, the
total number of patients per group varied (1-CMM: 239,
2-CMM+KneeKG: 121, 3-CMM+KneeKG+Education: 155). Of
515 randomized patients, 449 (87.2%) completed the ques-
tionnaires both at baseline and 6-month follow-up.
There were no statistically significant differences in socio-
demographic and clinical characteristics among the three treat-
ment groups at baseline (Tables 1 and 2). Participants’ mean
age was 63.6 years (95% Confidence Interval CI: 62.8;64.5) and
66.4% were females. They reported symptoms of knee OA for
a mean of 69.8 months (95%CI: 62.7;77.0), and KL grade was 2
in 33.0%, 3 in 38.8%, and 4 in 28.3% of the patients.
Outcome measures
Results of the statistical analyses of the between-group
differences showed a statistically significant time*group
interaction on all measures except for the Sports/Rec and
QOL subscales of the KOOS (Tables 3 and 4).
Primary outcome
Table 5 displays the results of the post-hoc analyses. There were
statistically significant group differences on the symptoms, pain
and ADL subscales, and overall KOOS score. Patients in both
KneeKG groups reported significantly higher scores on these 4
measures than those in the control Group 1-CMM. Considering
the mean intra-subject evolution, improvements in pain and
QOL scores reached the threshold of MCID in the two KneeKG
groups (2-CMM+KneeKG: pain = 12%, QOL = 17%; 3-CMM
+KneeKG+Education: pain = 11%, QOL = 13%) [25].
Results of the sensitivity analysis showed the same trend of
statistically significant differences on the KOOS measures,
except for the scores on the pain subscale which did not
quite reach statistical significance (p = 0.06) (Table 6).
Objective functional assessment
Isokinetic quadriceps strength test. As shown in Tables 3
and 5, patients in Group 3-CMM+KneeKG+Education exhibited
a statistically significant larger improvement in quadriceps
strength than those in the two other groups (1-CMM:
p < 0.001; 2-CMM+KneeKG: p = 0.02). Their mean improve-
ment of 0.5 (95%CI:0.3;0.6) Nm/Kg – i.e., +25% from baseline
to 6-month, is larger than the MCID [30].
30-second chair stand test (30sCST). Group 3-CMM+KneeKG
+Education (Tables 3 and 5) also showed a statistically signifi-
cant larger improvement on the 30sCST than the two other
groups (1-CMM: p < 0.001; 2-CMM+KneeKG: p = 0.01). At
Figure 3. The patient participation flow chart from reference to 6-month follow-up.
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Table 2. Mean baseline participant clinical characteristics.
TOTAL 1-CMM (Control) 2-CMM+KneeKG 3-CMM+KneeKG+Education
CI: Confidence interval N = 449 N = 213 N = 102 N = 134
CLINICAL CHARACTERISTICS N (%) or mean (95% CI) N (%) or mean (95% CI) N (%) or mean (95% CI) N (%) or mean (95% CI)
Duration of symptoms (months) 69.8 (62.7;77.0) 67.9 (58.3;77.6) 74.0 (57.5;90.5) 69.6 (55.8;83.5)
Pain intensity 6.5 (6.4;6.7) 6.5 (6.3;6.7) 6.4 (6.1;6.8) 6.7 (6.4;7.0)
KL grade
Grade 2 148 (33.0%) 72 (33.8%) 35 (34.5%) 41 (30.6%)
Grade 3 174 (38.8%) 89 (41.8%) 37 (36.3%) 48 (35.8%)
Grade 4 127 (28.3%) 52 (24.4%) 30 (29.4%) 45 (33.6%)
KOOS
Symptoms 63.8 (62.3;65.4) 65.5 (63.2;67.9) 62.7 (59.6;65.8) 62.2 (59.0;65.0)
Pain 60.4 (58.8;62.0) 62.1 (59.9;64.4) 58.4 (55.3;61.5) 59.1 (56.0;62.2)
Activities of daily living 67.0 (65.3;68.7) 68.3 (65.9;70.7) 66.3 (62.8;69.8) 65.5 (62.0;68.8)
Sports and recreation 37.2 (34.9;39.6) 37.5 (34.1;41.0) 39.1 (34.1;44.1) 35.3 (31.1;39.5)
Quality of life 50.9 (48.7;53.0) 51.9 (48.8;55.0) 50.5 (45.9;55.1) 49.5 (45.5;53.3)
Overall score 55.9 (48.8;53.0) 57.1 (54.9;59.3) 55.4 (52.2;58.6) 54.4 (51.5;57.3)
N = 226 N = 75 N = 73 N = 78
Functional tests
Quadriceps strength (Nm/kg) 2.2 (2.1;2.3) 2.3 (2.1;2.5) 2.3 (2.1;2.5) 2.0 (1.8;2.2)
30sCST (N of repetitions) 12.8 (12.2;13.3) 12.3 (11.3;13.2) 13.6 (12.7;14.6) 12.4 (11.5;13.3)
P-values are not presented in this table as they are all higher than 0.05.
As mentioned in the Methods section, functional tests were only performed in a subgroup of patients (N = 226).
Table 1. Mean baseline participant sociodemographic characteristics.
TOTAL 1-CMM (Control) 2-CMM+KneeKG 3-CMM+KneeKG+Education
CI: Confidence interval N = 449 N = 213 N = 102 N = 134
N (%) or N (%) or N (%) or N (%) or
SOCIODEMOGRAPHICS mean (95% CI) mean (95% CI) mean (95% CI) mean (95% CI)
Sex (women) 298 (66.4%) 151 (70.9%) 67 (65.7%) 80 (59.7%)
Age (years) 63.6 (62.8;64.5) 63.8 (62.5;65.0) 62.8 (61.0;64.5) 64.0 (62.4;65.7)
BMI (kg/m2) 30.0 (29.4;30.6) 29.9 (29.1;30.8) 29.9 (28.7;31.2) 30.1 (29.1;31.1)
Education level
Primary school 22 (4.9%) 10 (4.7%) 6 (5.9%) 6 (4.5%)
Secondary school 157 (35.0%) 68 (31.9%) 36 (35.3%) 53 (39.6%)
High school 137 (30.5%) 70 (32.9%) 30 (29.4%) 37 (27.6%)
College or higher 133 (29.6%) 65 (30.5%) 30 (29.4%) 38 (28.4%)
Family income ($CAD)
Less than 34 999 $ 72 (16.0%) 30 (14.1%) 17 (16.7%) 25 (18.7%)
35 000–49 999 $ 81 (18.0%) 41 (19.2%) 13 (12.7%) 27 (20.1%)
50 000–64 999 $ 61 (13.6%) 26 (12.2%) 16 (15.7%) 19 (14.2%)
65 000–79 999 $ 45 (10.0%) 26 (12.2%) 9 (8.8%) 10 (7.5%)
80 000–119 999 $ 58 (12.9%) 29 (13.6%) 17 (16.7%) 12 (9.0%)
More than 120 000 $ 35 (7.8%) 11 (5.2%) 11 (10.8%) 13 (9.7%)
Did not answer 97 (21.6%) 50 (23.5%) 19 (18.6%) 28 (20.9%)
P-values are not presented in this table as they are all higher than 0.05.
Table 3. Between-group differences on KOOS and functional testing measures between baseline and 6-month follow-up.
p ≤ 0.05: *; p < 0.001: ** 1-CMM (Control) 2-CMM+KneeKG 3-CMM+KneeKG+Education Statistical analyses
CI: Confidence interval N = 213 N = 102 N = 134 p-value
6-month minus 6-month minus 6-month minus Time*group
OUTCOMES Baseline score Baseline score Baseline score interaction
Mean (95% CI) Mean (95% CI) Mean (95% CI)
KOOS
Symptoms * 0.7 (−1.2;2.5) 4.6 (1.4;7.7) 4.6 (2.0;7.2) p = 0.02
Pain * 2.9 (0.9;4.8) 6.9 (4.1;9.8) 6.3 (3.5;9.0) p = 0.03
Activities of daily living * 1.5 (−0.4;3.4) 5.6 (2.8;8.4) 4.8 (2.2;7.4) p = 0.03
Sports and recreation −0.1 (−3.2;2.9) 1.9 (−2.9;6.6) 2.9 (−1.0;6.8) p = 0.47
Quality of life 4.3 (1.9;6.9) 8.4 (4.2;12.6) 6.5 (3.1;9.9) p = 0.21
Overall score * 1.8 (0.2;3.5) 5.5 (2.9;8.0) 5.0 (2.8;7.2) p = 0.02
Functional tests (N = 226) N = 75 N = 73 N = 78
Quadriceps strength (Nm/kg) ** − 0.1 (−0.3;0.0) 0.1 (−0.2;0.3) 0.5 (0.3;0.6) p < 0.001
30sCST (N of repetitions) * 0.5 (0.0;1.0) 0.7 (0.0;1.4) 1.7 (1.0;2.5) p = 0.01
KOOS: 0 = extreme symptoms and 100 = no symptoms; Quadriceps strength: the higher the better; 30sCST: the higher the number of repetitions the better.
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Table 5. Post-hoc analyses of outcome measures between baseline and 6-month follow-up.
p ≤ 0.05: *; p < 0.001: ** 2-CMM+KneeKG 3-CMM+KneeKG+Education 3-CMM+KneeKG+Education
VS VS VS
1-CMM (Control) 1-CMM (Control) 2-CMM+KneeKG
Δ 2–1 (p-value) Δ 3–1 (p-value) Δ 3–2 (p-value)
OUTCOMES
KOOS
Symptoms 3.9 (p = 0.03) * 3.9 (p = 0.01) * 0.0 (p = 0.98)
Pain 4.0 (p = 0.02) * 3.4 (p = 0.04) * −0.6 (p = 0.75)
Activities of daily living 4.1 (p = 0.02) * 3.3 (p = 0.04) * −0.8 (p = 0.68)
Overall score 3.7 (p = 0.02) * 3.2 (p = 0.02) * −0.5 (p = 0.79)
Functional tests
Quadriceps strength (Nm/kg) 0.2 (p = 0.07) 0.6 (p < 0.001) ** 0.4 (p = 0.02) *
30sCST (N of repetitions) 0.2 (p = 0.93) 1.2 (p < 0.001) ** 1.0 (p = 0.01) *
Patient global impression of change,
Patients who reported improvement to considerable improvement
Pain −2.9% (p = 0.33) 14.1% (p < 0.001) ** 17.0% (p < 0.001) **
Function −3.1% (p = 0.31) 9.6% (p = 0.03) * 12.7% (p = 0.02) *
Quality of life −0.7% (p = 0.50) 11.2% (p < 0.01) * 11.9% (p = 0.02) *
Global condition −0.3% (p = 0.54) 16.3% (p < 0.001) ** 16.6% (p < 0.001) **
Percentage of Pain relief −0.6% (p = 0.88) 8.6% (p = 0.02) * 9.2% (p = 0.04) *
Satisfaction with Global Care,
Patients who reported being satisfied or very satisfied 13.3% (p = 0.01) * 15.4% (p < 0.001) ** 2.1% (p = 0.26)
KOOS: 0 = extreme symptoms and 100 = no symptoms; Quadriceps strength: the higher the better; 30sCST: the higher the number of repetitions the better.
Table 6. Results of the sensitivity analysis on KOOS scores: between-group differences and post-hoc analyses.
p ≤ 0.05: *; p < 0.001: ** Time*group
CI: Confidence interval 1-CMM (Control) 2-CMM+KneeKG 3-CMM+KneeKG+Education p-value
N = 488 participants N = 223 (45.7%) N = 117 (24.0%) N = 148 (30.3%)
6-month minus 6-month minus 6-month minus
PRIMARY OUTCOME Baseline score Baseline score Baseline score
Mean (95% CI) Mean (95% CI) Mean (95% CI)
KOOS
Symptoms * 0.6 (−1.2;2.4) 4.0 (1.2;6.7) 4.2 (1.8;6.5) p = 0.03
Pain 2.7 (0.8;4.6) 6.1 (3.5;8.6) 5.7 (3.2;8.2) p = 0.06
Activities of daily living * 1.4 (−0.4;3.3) 4.9 (2.4;7.3) 4.3 (1.9;6.7) p = 0.05
Sports and recreation −0.1 (−3.1;2.8) 1.6 (−2.5;5.8) 2.6 (−0.9;6.1) p = 0.49
Quality of life 4.1 (1.8;6.5) 7.3 (3.7;11.0) 5.9 (2.8;9.0) p = 0.32
Overall score * 1.8 (0.1;3.4) 4.8 (2.5;7.0) 4.5 (2.5;6.5) p = 0.04
2-CMM+KneeKG 3-CMM+KneeKG+Education 3-CMM+KneeKG+Education
POST-HOC ANALYSIS VS VS VS
1-CMM (Control) 1-CMM (Control) 2-CMM+KneeKG
KOOS
Symptoms p = 0.04 * p = 0.02 * p = 0.91
Activities of daily living p = 0.03 * p = 0.05 * p = 0.75
Overall score p = 0.03 * p = 0.03 * p = 0.88
KOOS: 0 = extreme symptoms and 100 = no symptoms; Quadriceps strength: the higher the better; 30sCST: the higher the number of repetitions the better.
Table 4. Between-group differences on patient global impression of change and patient satisfaction with global care measures between baseline and 6-month
follow-up.
p ≤ 0.05: *; p < 0.001: ** 1-CMM (Control) 2-CMM+KneeKG 3-CMM+KneeKG+Education Statistical analyses
CI: Confidence interval N = 213 N = 102 N = 134 p-value
OUTCOMES N (%) N (%) N (%) Time*group
Patient global impression of change, interaction
Patients who reported improvement
to considerable improvement
Pain ** 48 (22.5%) 20 (19.6%) 49 (36.6%) p < 0.001
Function * 40 (18.8%) 16 (15.7%) 38 (28.4%) p = 0.03
Quality of life * 35 (16.4%) 16 (15.7%) 37 (27.6%) p = 0.02
Global condition ** 32 (15.0%) 15 (14.7%) 42 (31.3%) p < 0.001
Pain relief *, Mean (95% CI) 33.3% (28.4;38.2) 32.7% (26.5;38.9) 41.9% (36.4;47.3) p = 0.04
Satisfaction with Global Care ** Chi-square
- Patients who reported being satisfied or very satisfied 99 (46.5%) 61 (59.8%) 83 (61.9%) p < 0.001
- Patients who did not consider that they had been taking care of 49 (23.0%) 9 (8.8%) 5 (3.7%)
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6 months, they were able to perform almost 2.0 additional
repetitions (MCID threshold) from their baseline assessment
(+1.7 (95%CI:1.0;2.5) [31].
Patient global impression of change
Results from the PGICS (Tables 4 and 5) showed a statistically
significantly larger proportion of patients in Group 3-CMM
+KneeKG+Education reporting that their pain, function, qual-
ity of life, and global condition had improved at 6 months
compared to the patients of the two other groups (1-CMM: all
p ≤ 0.02; 2-CMM+KneeKG: all p ≤ 0.04). Group 2-CMM+KneeKG
did not differ from Group 1-CMM on any of these measures
(Tables 4 and 5).
Satisfaction
Patients. Patients in the two KneeKG groups reported signifi-
cantly higher satisfaction levels with the global care they
received than those in the control group (2-CMM+KneeKG:
p = 0.01; 3-CMM+KneeKG+Education: p < 0.001). Almost one
out of four patients in the control 1-CMM group considered
that their knee OA had not been taken care of (23.0%) (Tables
4 and 5).
Primary care physicians. Among the 206 PCPs contacted, 158
(76.7%) replied. Of 72 PCPs from Group 1-CMM, 26 (36.1%)
indicated that they were satisfied with tools and means they
have at their disposal in their current medical practice. Of 86
PCPs who also had access to knee kinesiography for their
patients, 22 (64.7%) from Group 2-CMM+KneeKG and 37
(71.2%) from Group 3-CMM+KneeKG+Education were satisfied.
Adherence to recommended exercises and physical therapy
sessions
The majority of patients in both KneeKG groups were adher-
ent to recommended exercises for at least 3 months, and the
proportion was significantly higher in Group 3-CMM+KneeKG
+Education (118/134:88.1%) compared to Group 2-CMM
+KneeKG (71/102:69.8%)(p < 0.001). The proportion of
patients who reported having had a physical therapy session
during the 6 months of the study was significantly higher in
Group 2-CMM+KneeKG (25/102:24.5%) compared to the other
groups (1-CMM:10/213:4.7%; 3-CMM+KneeKG+Education:10/
134:7.5%) (both p < 0.001) but on average they had signifi-
cantly fewer sessions (2-CMM+KneeKG:2.0 sessions;
1-CMM:4.5; 3-CMM+KneeKG+Education:5.7) (both p < 0.02).
Discussion
KneeKG represents a validated tool that provides PCPs with
quantitative information on biomechanical markers and mis-
alignment issues that are recognized and correctable through
recommended targeted therapies and exercises. Results of this
clinical trial reflect improvements in objective and patient
reported clinical outcomes that can be achieved relative to
CMM, with the addition of a knee kinesiography examination
to the care pathway.
Self-reported outcome measures (KOOS) at 6-month follow-
up suggest that in the two groups in which PCPs had access to
knee kinesiography, patients reported fewer symptoms and
lower pain levels, and improved their perceived knee func-
tional status compared to the control group.
Interestingly, group differences were not only observed
on subjective measures: patients in Group 3-CMM+KneeKG
+Education performed significantly better than Group
1-CMM and Group 2-CMM+KneeKG on the two objective
functional tests. A significantly larger proportion of
patients followed the recommended exercises in this
group, suggesting that reinforcing patient adherence to
treatment recommendations by adding education and
supervision contributes to improvement in objective func-
tional performance [3]. The same appears to be true for
perceived global impression of change at 6-month follow-
up.
Furthermore, levels of satisfaction with global care in
the two KneeKG groups were significantly higher than in
the control group. Dissatisfaction in regards to the CMM
was highlighted by the fact that almost one patient out of
four patients in the control group felt that their knee OA
had not been taken care of [6]. Greater satisfaction in the
two KneeKG groups may result from additional attention
paid to their condition, but it also may be generated by
enhanced patient understanding of the causes of their
symptoms facilitated by the KneeKG results. A recent sys-
tematic review by Chou et al. highlighted the need OA
patients expressed for more information on the manage-
ment of their condition [38].
Another important finding is the difference in PCPs’ satis-
faction levels between groups. The proportion of PCPs who
were satisfied with the tools and means they had to guide and
manage their patients was almost two times higher for PCPs in
both KneeKG groups, as compared to those in Group 1-CMM.
This suggests that PCPs who had access to knee kinesiography
felt better equipped or empowered to design a tailored care
plan for their patients. Results on patient participation in
physical therapy sessions support previous findings that in
CMM, PCPs rarely refer their patients to this form of therapy
[39]. However, results in KneeKG groups suggest that adding
an educational program was sufficient for Group 3-CMM
+KneeKG+Education patients to correctly follow treatment
recommendations whereas some of the Group 2-CMM
+KneeKG patients compensate the lack of supervision in only
2 additional physical therapy sessions.
Study results further support published literature suggest-
ing that for PCPs to improve treatment outcomes for knee OA
patients, they should include structured therapy (education
and exercises) into the episode of care [40,41]. A KneeKG
exam may be a means to enhance referral to such therapy
as it allows objective quantification of mechanical factors
linked to OA progression to guide personalized data-driven
treatment. According to clinical guidelines (OARSI, American
Academy of Orthopaedic Surgeons), education and support
remain the essential tools to empower knee OA patients and
encourage them to take an active role in the management of
their condition.
One key factor that may be considered in assessing struc-
tured therapy effectiveness is limiting the number of required
sessions. This may be pertinent as OA affects an older
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population that may have difficulty attending multiple visits.
The current study, required at most three sessions in Group
3-CMM+KneeKG+Education, and involved only a single follow-
up visit with PCPs for Group 2-CMM+KneeKG to achieve super-
ior results relative to the control Group 1-CMM. We suggest
that adding a knee kinesiography exam could empower the
PCPs to prescribe patient specific recommendations and
thereby, lead to an efficient care pathway, without need for
more than 3 supervised sessions. It could thereby address the
gap created by the reluctance of PCPs to send their patients to
multiple sessions of physical therapy.
The worldwide economic burden of OA is great and con-
tinues to grow rapidly [42,43]. The increasing costs of OA can
be largely attributed to the increasing prevalence of the dis-
ease which is expected to double in the next 20 years, in part
driven by the obesity epidemic, and the high cost of required
treatment procedures as the disease progresses [44]. Hunter
suggested that greater therapeutic attention should be paid
to modifiable mechanical factors and obesity in OA to reduce
the public health impact of this disease [45]. The integration
into CMM of the knee kinesiography could facilitate objective
quantitative measurement of modifiable biomechanical risk
factors to identify misalignments at earlier stage in the disease
evolution. Consequently, this would allow HCPs to correct
them through targeted therapies and exercises. This could
significantly lower the risk of disease progression [3,46] and
may yield cost savings by delaying total knee arthroplasty and
subsequently reducing the number of expensive surgical revi-
sions [47].
Study limitations and strengths
The present study has several limitations. First, it was con-
ducted in a single province in Canada, which may limit the
generalizability of results to other provinces or countries. It
was however a multisite study involving multiple HCPs, and
educational sessions and interventions were carried out in 10
locations, supporting the feasibility of implementing KneeKG
in clinical practice. Availability of this technology is growing
across Canada and internationally and it is not anticipated that
the significance of these results would be altered if it were
applied in a broader context. Second, data collection methods
except for mechanical markers relied mostly on self-reports.
Errors may have been made during questionnaire completion.
However, quality controls were programmed into the online
questionnaires and the electronic database to allow instant
automated data validation checks (e.g., out-of-range values,
logical inconsistencies). Furthermore, research assistants con-
tacted participants to verify unclear or incomplete answers. In
the present study, PCPs were provided with the KneeKG exam
report but we did not assess the extent to which they applied
the treatment recommendations. However, participant adher-
ence to their prescribed exercise program was assessed. The
fact that objective functional tests were performed on
a smaller sample represents another limitation.
Despite these limitations, the present study has several
important strengths that merit mention. A cluster rando-
mized controlled trial was used, standardized knee X-Rays
were performed, KL OA grades were confirmed by a single
experienced musculoskeletal radiologist, standardized train-
ing of therapists was carried out, standardized recruitment
and data collection methods across study sites were used,
and validated and recommended measurement scales were
utilized. Furthermore, a statistical power calculation per-
formed by a biostatistician using study data (scores and
standard deviations on the KOOS global score) yielded
a score of 85%. We initially predicted that an 80% statistical
power would require 100 patients per group, but it appears
that we have been conservative on this prediction and that
the fact the final sample size is larger (449 patients) and has
less variability (standard deviation ~ 13) than expected pro-
vided adequate statistical power to the study, even though
the initial estimation of a 10-point difference on the KOOS
overall score was not reached. Finally, this study included
both objective and subjective outcome measures and was
conducted on a large sample size with limited selection bias
and impact of loss at follow-up (87.2% retention rate at
6-month follow-up).
Conclusion
Results of this randomized controlled clinical trial indicated that
patients in the two groups in which a knee kinesiography exam
was included in the care pathway reported greater reduction in
symptoms and pain relative to the control group (KOOS scales).
They also demonstrated improved perceived knee functional
status compared to the control group. In addition, patients in
Group 3-KneeKG+Education performed significantly better than
Group 1-CMM and Group 2-CMM+KneeKG on the two objective
functional tests. The patients in the 2-CMM-KneeKG and 3-CMM
+KneeKG+Education groups expressed higher satisfaction levels
than the control group. Of further note, PCPs’ satisfaction with
respect to tools and means they had at their disposal to guide
and manage their knee OA patients was significantly higher
when knee kinesiography was included.
Adding a validated assessment tool such as the KneeKG to
the CMM of non-surgical knee OA patients supports clinical
decision-making to guide conservative care pathways, and
measurement of dynamic mechanical misalignments, as per
current guidelines. As demonstrated in this study, this can
yield significant reduction of symptoms and pain, improve-
ment of function, and increased patient satisfaction with
a maximum of three supervised sessions over 4 months.
Adding an educational program to the supervision of PCPs
further improves outcomes, as demonstrated in the OA litera-
ture [48,49]. Results of this study may support the added value
of a dynamic knee functional test as they suggest that this
exam enhances PCPs’ capability and knowledge base to
recommend tailored conservative treatment strategies.
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